MTLS
Materialise NV [MTLS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
MTLS Stock Summary
Top 10 Correlated ETFs
MTLS
Top 10 Correlated Stocks
MTLS
In the News
MTLS Financial details
MTLS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 3.72 | 3.19 | 3.62 | 3.93 | 4.25 | |
| Net income per share | 0.03 | -0.14 | 0.23 | -0.04 | 0.11 | |
| Operating cash flow per share | 0.54 | 0.56 | 0.46 | 0.42 | 0.31 | |
| Free cash flow per share | 0.24 | 0.23 | 0.25 | 0 | 0.11 | |
| Cash per share | 2.44 | 2.09 | 3.46 | 2.38 | 2.16 | |
| Book value per share | 2.64 | 2.49 | 4.1 | 3.88 | 4.01 | |
| Tangible book value per share | 1.8 | 1.5 | 3.21 | 2.49 | 3.28 | |
| Share holders equity per share | 2.64 | 2.49 | 4.1 | 3.88 | 4.01 | |
| Interest debt per share | 2.49 | 2.27 | 1.82 | 1.45 | 1.06 | |
| Market cap | 860.84M | 2.37B | 1.19B | 487.17M | 351.09M | |
| Enterprise value | 859.89M | 2.37B | 1.1B | 427.29M | 287.86M | |
| P/E ratio | 522.99 | -325.45 | 90.83 | -226.28 | 53.32 | |
| Price to sales ratio | 4.38 | 13.88 | 5.82 | 2.1 | 1.4 | |
| POCF ratio | 30.31 | 78.94 | 46.23 | 19.72 | 19.47 | |
| PFCF ratio | 67.59 | 191.98 | 84.61 | -7.61K | 53.92 | |
| P/B Ratio | 6.17 | 17.78 | 5.14 | 2.13 | 1.48 | |
| PTB ratio | 6.17 | 17.78 | 5.14 | 2.13 | 1.48 | |
| EV to sales | 4.37 | 13.9 | 5.34 | 1.84 | 1.15 | |
| Enterprise value over EBITDA | 31.61 | 123.46 | 28.62 | 16.56 | 8.72 | |
| EV to operating cash flow | 30.28 | 79.06 | 42.48 | 17.29 | 15.97 | |
| EV to free cash flow | 67.51 | 192.27 | 77.75 | -6.68K | 44.21 | |
| Earnings yield | 0 | 0 | 0.01 | 0 | 0.02 | |
| Free cash flow yield | 0.01 | 0.01 | 0.01 | 0 | 0.02 | |
| Debt to equity | 0.92 | 0.86 | 0.43 | 0.35 | 0.25 | |
| Debt to assets | 0.37 | 0.35 | 0.24 | 0.2 | 0.15 | |
| Net debt to EBITDA | -0.04 | 0.19 | -2.53 | -2.32 | -1.91 | |
| Current ratio | 2.27 | 1.9 | 2.82 | 2.04 | 1.97 | |
| Interest coverage | 1.91 | -0.08 | 4.35 | 0.73 | 3.14 | |
| Income quality | 16.47 | -4.12 | 1.97 | -11.48 | 2.74 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.16 | 0.17 | 0.16 | 0.15 | 0 | |
| Research and developement to revenue | 0.12 | 0.16 | 0.13 | 0.16 | 0.15 | |
| Intangibles to total assets | 0.14 | 0.16 | 0.12 | 0.2 | 0.11 | |
| Capex to operating cash flow | -0.55 | -0.59 | -0.45 | -1 | -0.64 | |
| Capex to revenue | -0.08 | -0.1 | -0.06 | -0.11 | -0.05 | |
| Capex to depreciation | -0.82 | -0.9 | -0.57 | -1.1 | -0.55 | |
| Stock based compensation to revenue | 0 | 0 | -0.01 | 0 | -0.22 | |
| Graham number | 1.36 | 2.77 | 4.63 | 1.78 | 3.17 | |
| ROIC | 0.01 | 0 | 0.05 | 0.02 | 0.04 | |
| Return on tangible assets | 0.01 | -0.03 | 0.04 | -0.01 | 0.02 | |
| Graham Net | -0.78 | -1.03 | 0.92 | 0.08 | 0.26 | |
| Working capital | 107.14M | 76.3M | 166.37M | 110.3M | 101.6M | |
| Tangible asset value | 95.11M | 79.78M | 182.18M | 146.9M | 193.6M | |
| Net current asset value | -15.43M | -33.82M | 76.97M | 34.08M | 46.47M | |
| Invested capital | 0.92 | 0.86 | 0.43 | 0.35 | 0.25 | |
| Average receivables | 38.61M | 35.6M | 36.21M | 46.29M | 51.89M | |
| Average payables | 18.59M | 18.11M | 18.93M | 22.9M | 23.42M | |
| Average inventory | 11.34M | 11.37M | 10.67M | 13.69M | 16.56M | |
| Days sales outstanding | 74.83 | 66.11 | 73.8 | 80.3 | 76.73 | |
| Days payables outstanding | 77.71 | 84.5 | 83.5 | 90.59 | 71.22 | |
| Days of inventory on hand | 53.28 | 47.95 | 46.76 | 56.84 | 57.23 | |
| Receivables turnover | 4.88 | 5.52 | 4.95 | 4.55 | 4.76 | |
| Payables turnover | 4.7 | 4.32 | 4.37 | 4.03 | 5.13 | |
| Inventory turnover | 6.85 | 7.61 | 7.81 | 6.42 | 6.38 | |
| ROE | 0.01 | -0.05 | 0.06 | -0.01 | 0.03 | |
| Capex per share | -0.3 | -0.33 | -0.21 | -0.42 | -0.2 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.06 | 1.12 | 1.1 | 1.02 | 1.08 | |
| Net income per share | -0.08 | 0.06 | -0.01 | 0.07 | -0.01 | |
| Operating cash flow per share | -0.02 | 0.19 | 0.01 | 0.14 | -0.01 | |
| Free cash flow per share | -0.11 | 0.13 | -0.02 | 0.07 | -0.05 | |
| Cash per share | 2.38 | 2.4 | 2.31 | 2.27 | 2.16 | |
| Book value per share | 3.88 | 3.95 | 3.95 | 4.01 | 4.01 | |
| Tangible book value per share | 2.49 | 2.58 | 2.59 | 2.65 | 3.28 | |
| Share holders equity per share | 3.88 | 3.95 | 3.95 | 4.01 | 4.01 | |
| Interest debt per share | 1.44 | 1.3 | 1.24 | 1.15 | 1.01 | |
| Market cap | 487.2M | 449.58M | 469.58M | 309.39M | 351.09M | |
| Enterprise value | 427.31M | 383.12M | 405.71M | 241.66M | 287.86M | |
| P/E ratio | -26.55 | 30.21 | -240.56 | 19.26 | -170.29 | |
| Price to sales ratio | 7.77 | 6.82 | 7.25 | 5.15 | 5.52 | |
| POCF ratio | -375.06 | 40.71 | 605.91 | 37.99 | -777.5 | |
| PFCF ratio | -74 | 57.83 | -349.39 | 73.26 | -129.18 | |
| P/B Ratio | 2.13 | 1.93 | 2.01 | 1.31 | 1.48 | |
| PTB ratio | 2.13 | 1.93 | 2.01 | 1.31 | 1.48 | |
| EV to sales | 6.81 | 5.81 | 6.26 | 4.02 | 4.52 | |
| Enterprise value over EBITDA | -552.08 | 34.46 | 66.56 | 22.56 | 39.42 | |
| EV to operating cash flow | -328.96 | 34.69 | 523.49 | 29.67 | -637.48 | |
| EV to free cash flow | -64.9 | 49.28 | -301.86 | 57.23 | -105.92 | |
| Earnings yield | -0.01 | 0.01 | 0 | 0.01 | 0 | |
| Free cash flow yield | -0.01 | 0.02 | 0 | 0.01 | -0.01 | |
| Debt to equity | 0.35 | 0.32 | 0.31 | 0.28 | 0.25 | |
| Debt to assets | 0.2 | 0.18 | 0.18 | 0.17 | 0.15 | |
| Net debt to EBITDA | 77.37 | -5.98 | -10.48 | -6.32 | -8.66 | |
| Current ratio | 2.04 | 2.03 | 2.11 | 2.15 | 1.97 | |
| Interest coverage | -0.37 | 3.63 | -0.89 | 1.5 | 8.17 | |
| Income quality | 0.28 | 2.97 | -1.57 | 2.03 | 0.88 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.14 | 0.14 | 0.15 | 0.14 | 0 | |
| Research and developement to revenue | 0.18 | 0.14 | 0.15 | 0.16 | 0.15 | |
| Intangibles to total assets | 0.2 | 0.2 | 0.2 | 0.2 | 0.11 | |
| Capex to operating cash flow | 4.07 | -0.3 | -2.73 | -0.48 | 5.02 | |
| Capex to revenue | -0.08 | -0.05 | -0.03 | -0.07 | -0.04 | |
| Capex to depreciation | -0.83 | -0.62 | -0.39 | -0.71 | -0.44 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0.01 | -0.38 | |
| Graham number | 2.6 | 2.37 | 0.86 | 2.48 | 0.89 | |
| ROIC | 0 | 0.01 | 0.02 | 0.01 | 0 | |
| Return on tangible assets | -0.01 | 0.01 | 0 | 0.01 | 0 | |
| Graham Net | 0.08 | 0.18 | 0.2 | 0.28 | 0.26 | |
| Working capital | 110.3M | 108.37M | 108.75M | 107.22M | 101.6M | |
| Tangible asset value | 146.9M | 152.11M | 153.27M | 156.76M | 193.6M | |
| Net current asset value | 34.08M | 38.84M | 40.22M | 43.46M | 46.47M | |
| Invested capital | 0.35 | 0.32 | 0.31 | 0.28 | 0.25 | |
| Average receivables | 46.69M | 49.41M | 46.82M | 43.93M | 47.37M | |
| Average payables | 25.33M | 24.7M | 23.28M | 21.79M | 21.01M | |
| Average inventory | 15.81M | 15.95M | 15.91M | 16.39M | 16.91M | |
| Days sales outstanding | 73.26 | 65.27 | 63.68 | 62.86 | 74.61 | |
| Days payables outstanding | 85.36 | 73.66 | 73.88 | 70.81 | 70.62 | |
| Days of inventory on hand | 53.56 | 48.98 | 51.89 | 57.07 | 56.75 | |
| Receivables turnover | 1.23 | 1.38 | 1.41 | 1.43 | 1.21 | |
| Payables turnover | 1.05 | 1.22 | 1.22 | 1.27 | 1.27 | |
| Inventory turnover | 1.68 | 1.84 | 1.73 | 1.58 | 1.59 | |
| ROE | -0.02 | 0.02 | 0 | 0.02 | 0 | |
| Capex per share | -0.09 | -0.06 | -0.04 | -0.07 | -0.04 |
MTLS Frequently Asked Questions
What is Materialise NV stock symbol ?
Materialise NV is a BE stock and trading under the symbol MTLS
What is Materialise NV stock quote today ?
Materialise NV stock price is $5.08 today.
Is Materialise NV stock public?
Yes, Materialise NV is a publicly traded company.
Company Profile
- Volume Average 89.99K
- Market Capitalization 300.06M
- Employee 2.44K
- CEO Ms. Brigitte de Vet-Veithen
- Headquarters Leuven,BE
- IPO Date 2014-06-25
-
Website
https://www.materialise.com 
Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The company's Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. Its Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
